(PharmaNewsWire.Com, May 12, 2017 ) “Asia-Pacific Biomarkers Market" research report published by Market Data Forecast estimates that the market is growing with a CAGR of 16.20% to reach USD 9.198 billion by 2021, from USD 4.808 billion in 2016, which amounts to a cumulative growth of USD 4.39 billion.
Biomarkers are also known as molecular markers or signature molecules, defined as the biological molecules or genes assist in critical clinical decisions and diagnosis of health conditions in patients. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
These are used to predict the pharmacologic responses, pathological & biological conditions so that appropriate therapeutic intervention can be planned. Biomarkers are the measures that are used to execute a clinical assessment such as cholesterol level or blood pressure and are used to monitor and analyse health states in individuals or across populations. Biomarkers may be used in combination or alone to assess the health or disease state of an individual.
The report also presents detailed analysis of multitude of factors affecting Asia-Pacific Biomarkers Market bearing either positive or negative outcomes. Some of those factors are • Rising demand for diagnostic tests to aware of health conditions, • Increasing number of cancer patients, • Growing focus of foreign pharmaceutical companies on Asian market • Increasing involvement of universities & research institutes • Growing demand for advanced healthcare facilities in certain Asian countries such as India & China • Rising number of clinical trials are further stimulating the growth of biomarkers market in Asia-Pacific region • Low adoption of advanced biomarkers tests and high cost of biomarkers developments & validation.
For granular level understanding, the Asia-Pacific Biomarkers Market is segmented based on product, type, application, and disease indications each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on product, the market is further sub-segmented as consumables, software, and services. Based on type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Developing countries in this region such as India and China are projected to witness significant growth in the Plant Growth Regulators market due to the large-scale cotton industries and increasing acceptance of sustainable farming in this region.
The Asia-Pacific Biomarkers Market report offers wide-range of scope: • Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries • Know more about key areas of industry growth via detailed Segment-level analysis on basis of product, type, application, and disease indications with market size forecasts and y-o-y estimations • Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics • Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics • Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Asia-Pacific Biomarkers Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
